- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$28.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$196.15
7D
-3.2%
1Y
32.3%
BioNTech
Market Cap: US$21.3b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$87.46
7D
-2.1%
1Y
-8.3%
Illumina
Market Cap: US$19.3b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$124.40
7D
-1.7%
1Y
51.2%
Sam Chun Dang Pharm
Market Cap: ₩26.9t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩1,158,000.00
7D
45.7%
1Y
543.3%
Elanco Animal Health
Market Cap: US$12.7b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.58
7D
-2.1%
1Y
127.4%
Regencell Bioscience Holdings
Market Cap: US$11.9b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$25.40
7D
-6.0%
1Y
2,668.0%